Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Theodore Thomas

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
Journal of Hematology & Oncology|January 8, 2024
The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era VeteransLawrence W Liu, Mei Wang, Nikhil Grandhi, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 12, 2018
Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysisTara R Semenkovich, Roheena Z Panni, Jessica L Hudson, et al.
JNCI Cancer Spectrum|November 8, 2024
Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetesNikhil Grandhi, Lawrence Liu, Mei Wang, et al.
JAMA Network Open|February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to MyelomaLawrence Liu, Nikhil Grandhi, Mei Wang, et al.
American Journal of Hematology|August 6, 2019
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE scoreKristen M Sanfilippo, Suhong Luo, Tzu-Fei Wang, et al.
JTCVS Open|February 29, 2024
Lobe-specific lymph node sampling is associated with lower risk of cancer recurrenceMelanie P Subramanian, Daniel B Eaton, Brendan T Heiden, et al.
JNCI Cancer Spectrum|May 21, 2026
Trends in lung cancer survival: superior outcomes in US veterans compared to general populationNikki E Rossetti, Brendan T Heiden, Daniel B Eaton, et al.
Oncotarget|September 2, 2015
Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumorsEusebio S Pires, Ryan S D'Souza, Marisa A Needham, et al.
The Annals of Thoracic Surgery|September 4, 2025
Synchronous Primary Early-Stage Non-Small Cell Lung Cancer: Trends in Management and Factors Associated with Improved SurvivalWhitney S Brandt, Nikki E Rossetti, Daniel B Eaton, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Hematology & Oncology|January 8, 2024
The Association of Agent Orange Exposure with the progression of monoclonal gammopathy of undetermined significance to multiple myeloma: a population-based study of Vietnam War Era VeteransLawrence W Liu, Mei Wang, Nikhil Grandhi, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 12, 2018
Comparative effectiveness of upfront esophagectomy versus induction chemoradiation in clinical stage T2N0 esophageal cancer: A decision analysisTara R Semenkovich, Roheena Z Panni, Jessica L Hudson, et al.
JNCI Cancer Spectrum|November 8, 2024
Association between glucagon-like peptide-1 receptor agonist use and progression of monoclonal gammopathy of uncertain significance to multiple myeloma among patients with diabetesNikhil Grandhi, Lawrence Liu, Mei Wang, et al.
JAMA Network Open|February 7, 2025
Cumulative Excess Body Mass Index and MGUS Progression to MyelomaLawrence Liu, Nikhil Grandhi, Mei Wang, et al.
American Journal of Hematology|August 6, 2019
Predicting venous thromboembolism in multiple myeloma: development and validation of the IMPEDE VTE scoreKristen M Sanfilippo, Suhong Luo, Tzu-Fei Wang, et al.
JTCVS Open|February 29, 2024
Lobe-specific lymph node sampling is associated with lower risk of cancer recurrenceMelanie P Subramanian, Daniel B Eaton, Brendan T Heiden, et al.
JNCI Cancer Spectrum|May 21, 2026
Trends in lung cancer survival: superior outcomes in US veterans compared to general populationNikki E Rossetti, Brendan T Heiden, Daniel B Eaton, et al.
Oncotarget|September 2, 2015
Membrane associated cancer-oocyte neoantigen SAS1B/ovastacin is a candidate immunotherapeutic target for uterine tumorsEusebio S Pires, Ryan S D'Souza, Marisa A Needham, et al.
The Annals of Thoracic Surgery|September 4, 2025
Synchronous Primary Early-Stage Non-Small Cell Lung Cancer: Trends in Management and Factors Associated with Improved SurvivalWhitney S Brandt, Nikki E Rossetti, Daniel B Eaton, et al.
Pageof 2